A recent study published in NEJM Evidence indicates that ulipristal acetate, the active drug in the morning-after pill Ella, may be a viable substitute for the abortion pill mifepristone. The study involved 133 women up to nine weeks pregnant, with a 97% success rate in terminating pregnancies using a higher dose of ulipristal followed by misoprostol. No serious complications were reported, highlighting its potential as a safe option in the current political climate surrounding reproductive health.
A new study shows that ulipristal acetate, the active ingredient in Ella, could serve as a safe and effective alternative to the abortion pill mifepristone.
The study found a 97% completion rate for using ulipristal acetate with misoprostol for abortions, which mirrors the effectiveness of the regimen involving mifepristone.
Collection
[
|
...
]